Ubs Group Ag Ocugen, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Ocugen, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,024,879 shares of OCGN stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,024,879

Previous 654,379 56.62%

Holding current value

$1.22 Million

Previous $634,000 163.41%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$0.92 - $1.66 $340,860 - $615,030	370,500 Added 56.62%	1,024,879 $1.67 Million
Q2 2025 Aug 14, 2025	SELL	$0.58 - $1.2 $2.15 Million - $4.46 Million	-3,713,401 Reduced 85.02%	654,379 $634,000
Q1 2025 May 13, 2025	BUY	$0.52 - $0.9 $1.76 Million - $3.05 Million	3,393,137 Added 348.14%	4,367,780 $3.1 Million
Q4 2024 Feb 14, 2025	BUY	$0.72 - $1.08 $292,158 - $438,238	405,776 Added 71.33%	974,643 $779,000
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $103,910 - $206,760	106,031 Added 22.91%	568,867 $563,000

Q2 2024 Aug 13, 2024	BUY	$1.18 - $1.98 $529,409 - $888,330	448,652 Added 3163.09%	462,836 $717,000
Q1 2024 May 13, 2024	BUY	$0.5 - $1.83 $5,189 - $18,993	10,379 Added 272.77%	14,184 $23,000
Q4 2023 Feb 09, 2024	SELL	$0.36 - $0.57 $7,392 - $11,705	-20,536 Reduced 84.37%	3,805 $2,000
Q3 2023 Nov 09, 2023	BUY	$0.4 - $0.62 $6,125 - $9,494	15,314 Added 169.65%	24,341 $9,000
Q2 2023 Aug 11, 2023	SELL	$0.45 - $0.88 $42,746 - $83,592	-94,992 Reduced 91.32%	9,027 $4,000
Q1 2023 May 12, 2023	SELL	$0.82 - $1.33 $1.2 Million - $1.95 Million	-1,468,021 Reduced 93.38%	104,019 $88,000
Q4 2022 Feb 08, 2023	BUY	$1.11 - $1.87 $1.42 Million - $2.4 Million	1,283,489 Added 444.8%	1,572,040 $2.04 Million
Q3 2022 Nov 10, 2022	SELL	$1.75 - $3.1 $1.02 Million - $1.81 Million	-585,442 Reduced 66.98%	288,551 $514,000
Q2 2022 Aug 10, 2022	SELL	$1.83 - $3.45 $2.3 Million - $4.34 Million	-1,257,081 Reduced 58.99%	873,993 $1.98 Million
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $3.05 Million - $6.16 Million	1,305,248 Added 158.05%	2,131,074 $7.03 Million
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $1.76 Million - $6.3 Million	402,227 Added 94.95%	825,826 $3.76 Million
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $2.37 Million - $3.17 Million	372,609 Added 730.75%	423,599 $3.04 Million
Q2 2021 Aug 13, 2021	SELL	$5.52 - $15.68 $484,738 - $1.38 Million	-87,815 Reduced 63.27%	50,990 $409,000
Q1 2021 May 12, 2021	BUY	$1.66 - $15.81 $230,348 - $2.19 Million	138,764 Added 338448.78%	138,805 $942,000
Q4 2020 Feb 11, 2021	SELL	$0.28 - $2.6 $22,459 - $208,551	-80,212 Reduced 99.95%	41 $0
Q3 2020 Nov 12, 2020	SELL	$0.2 - $0.72 $19,767 - $71,163	-98,838 Reduced 55.19%	80,253 $25,000
Q2 2020 Jul 31, 2020	BUY	$0.22 - $0.46 $35,698 - $74,642	162,266 Added 964.43%	179,091 $39,000
Q1 2020 May 01, 2020	BUY	$0.26 - $0.73 $4,368 - $12,264	16,800 Added 67200.0%	16,825 $5,000
Q3 2019 Nov 14, 2019	BUY	$2.85 - $16.26 $71 - $406	25 New	25 $0

Others Institutions Holding OCGN

# of Institutions

106

Shares Held

60.4M

Call Options Held

531K

Put Options Held

433K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $258M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account